Profil
Dr. Alexandre Kaoukhov is a Chief Medical Officer at Aslan Pharmaceuticals Ltd. Dr. Kaoukhov was previously employed as a Senior Vice President & Head-Clinical Development by Bioniz Therapeutics, Inc., a Head-Global Development by Almirall SA, and a Head-Global Development by Allergan, Inc. He received his doctorate degree from I.M.
Sechenov First Moscow State Medical University.
Aktive Positionen von Alexandre Kaoukhov
| Unternehmen | Position | Beginn |
|---|---|---|
| ASLAN PHARMACEUTICALS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 15.03.2022 |
Ehemalige bekannte Positionen von Alexandre Kaoukhov
| Unternehmen | Position | Ende |
|---|---|---|
Bioniz Therapeutics, Inc.
Bioniz Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage biotechnology company | Corporate Officer/Principal | - |
| ALMIRALL, S.A. | Corporate Officer/Principal | 01.11.2020 |
| ALLERGAN, INC. | Corporate Officer/Principal | 01.01.2018 |
Ausbildung von Alexandre Kaoukhov
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Almirall SA
Almirall SA Pharmaceuticals: MajorHealth Technology Engages in the development, manufacture and sale of pharmaceuticals | Health Technology |
Bioniz Therapeutics, Inc.
Bioniz Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage biotechnology company | Commercial Services |
I.M. Sechenov First Moscow State Medical University
I.M. Sechenov First Moscow State Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aslan Pharmaceuticals Ltd.
Aslan Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as biotechnology company which develops immuno-oncology agents and targeted therapies | Health Technology |
















